SCHEMBL2879865

SCHEMBL2879865

O=S(=O)(Cl)CCc1ccccc1C(F)(F)F

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.44
DAO P14920 1/20 0.44
NPSR1 Q6W5P4 1/20 0.43
CNR1 P21554 1/20 0.43
DPP4 P27487 1/20 0.42
DPP8 Q6V1X1 1/20 0.42
ALDH1A1 P00352 5/20 0.41
KDM4E B2RXH2 4/20 0.41
ATM Q13315 1/20 0.41
TDP1 Q9NUW8 2/20 0.41
RECQL P46063 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
AKR1B1 P15121 1/20 0.41
KMT2A Q03164 2/20 0.40
HPGD P15428 1/20 0.39
POLQ O75417 1/20 0.39
SLC6A2 P23975 1/20 0.38
SLC6A4 P31645 1/20 0.38
SLC6A3 Q01959 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18240882 0.82 IDO1 (0.44) IDO1DAONPSR1CNR1DPP4
SCHEMBL9843663 0.82 IDO1 (0.49) IDO1DAONPSR1CNR1DPP4
SCHEMBL31405393 0.81 AKR1B1 (0.50) IDO1DAONPSR1CNR1ALDH1A1
SCHEMBL270629 0.81 AKR1B1 (0.50) IDO1DAONPSR1CNR1ALDH1A1
SCHEMBL27378976 0.81 IDO1 (0.43) IDO1DAONPSR1CNR1DPP4
SCHEMBL17329111 0.78 IDO1 (0.59) IDO1DAOCNR1DPP4DPP8
SCHEMBL28521875 0.76 HDAC1 (0.49) IDO1DAONPSR1CNR1ALDH1A1
SCHEMBL9844112 0.76 DAO (0.40) IDO1DAONPSR1CNR1DPP4
SCHEMBL31452193 0.76 TAAR1 (0.52) IDO1DAOCNR1ALDH1A1RECQL
SCHEMBL3257217 0.76 TAAR1 (0.52) IDO1DAOCNR1ALDH1A1RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8283373-B2 Inhibitors of cytosolic phospholipase A2 PFIZER INC. (US) 2012-10-09 US disclosed
EP-1891006-B1 INHIBITORS OF CYTOSOLIC PHOSPHOLIPASE A2 WYETH LLC (US) 2010-11-24 EP disclosed
EP-2248801-A1 Inhibitors of cytosolic phospholipase a2 Wyeth LLC (US) 2010-11-10 EP disclosed
US-20100029645-A1 Inhibitors of Cytosolic Phospholipase A2 WYETH LLC 2010-02-04 US disclosed
US-20100022536-A1 Inhibitors of Cytosolic Phospholipase A2 NOVARTIS AG (CH) 2010-01-28 US disclosed
US-7557135-B2 Inhibitors of cytosolic phospholipase A2 WYETH (US) 2009-07-07 US disclosed
EP-1891006-A2 INHIBITORS OF CYTOSOLIC PHOSPHOLIPASE A2 Wyeth a Corporation of the State of Delaware (US) 2008-02-27 EP disclosed
US-20070004719-A1 Inhibitors of cytosolic phospholipase A2 WYETH (US) 2007-01-04 US disclosed
WO-2006128142-A2 INHIBITORS OF CYTOSOLIC PHOSPHOLIPASE A2 WYETH (US) 2006-11-30 WO disclosed
EP-0447645-A1 Aralkylesulfonyl ureas BAYER AG (DE) 1991-09-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100022536-A1 Inhibitors of Cytosolic Phospholipase A2 PLA2G4B, PLA2G4A, PLA2G12A IDO1 851/4885DAO 1506/4885NPSR1 3332/4885
US-20100029645-A1 Inhibitors of Cytosolic Phospholipase A2 PLA2G4B, PLA2G4A, PLA2G12A IDO1 851/4885DAO 1506/4885NPSR1 3332/4885
US-20070004719-A1 Inhibitors of cytosolic phospholipase A2 PLA2G4B, PLA2G4A, PLA2G12A IDO1 851/4885DAO 1506/4885NPSR1 3332/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.